文章摘要
吕杰,刘在美.益心舒片联合曲美他嗪治疗对慢性心力衰竭心功能参数及Adropin蛋白水平的影响[J].中国临床保健杂志,2019,22(6):783-785.
益心舒片联合曲美他嗪治疗对慢性心力衰竭心功能参数及Adropin蛋白水平的影响
The effects of Yixinshu Tablets combined with trimetazidine treatment on cardiac function parameters and Adropin protein levels in patients with chronic heart failure
投稿时间:2019-09-02  
DOI:10.3969/J.issn.1672-6790.2019.06.016
中文关键词: 心力衰竭  曲美他嗪  中成药  多种药物疗法  Adropin蛋白
英文关键词: Heart failure  Trimetazidine  Chinese Patent Drugs  Polypharmacy  Adropin protein 〖FL
基金项目:
作者单位E-mail
吕杰 山东济南市人民医院老年病科,271100 1037888071@qq.com 
刘在美 山东济南市人民医院老年病科,271100  
摘要点击次数: 98
全文下载次数: 104
中文摘要:
      目的 探讨益心舒片联合曲美他嗪治疗对慢性心力衰竭心功能参数及Adropin蛋白水平的影响。方法 选取住院的86例慢性心力衰竭患者为研究对象,按随机数字表法分为对照组和试验组,每组43例。对照组给予盐酸贝那普利、琥珀酸美托洛尔缓释、氢氯噻嗪、螺内酯、地高辛及盐酸曲美他嗪等药物治疗;试验组在上述治疗基础上加用益心舒片,3片/次,3次/天。两组患者均连续治疗12周。超声心动图检测治疗前后两组心室射血分数(LVEF)、室间隔厚度(IVSD)、左心室舒张末内径(LVEDD)、左心室后壁厚度(LVPW)变化并进行比较;检测氨基末端脑利钠肽前体(NT-proBNP)及Adropin蛋白治疗前后水平变化并进行比较。结果 治疗后,对照组总有效率为69.8%,试验组总有效率为88.4%,两组总有效率差异有统计学意义(P<0.05)。治疗后两组LVEDD、IVSD、LVPW较治疗前明显降低,且试验组LVEDD、IVSD、LVPW低于对照组(P<0.05)。治疗后两组LVEF较治疗前明显升高,而NT-proBNP及Adropin蛋白较治疗前明显降低;治疗后试验组LVEF高于对照组,而NT-proBNP及Adropin蛋白治疗后明显低于对照组,差异均有统计学意义(P<0.05)。结论 益心舒片联合曲美他嗪治疗慢性心力衰竭具有较好的临床疗效,能延缓病情进展,从而可对改善患者心力衰竭症状获益。
英文摘要:
      Objective To explore the effects of Yixinshu Tablets combined with trimetazidine treatment on cardiac function parameters and Adropin protein levels in patients with chronic heart failure (CHF).Methods A total of 86 cases with CHF collected were randomly divided into control and test groups,and each group had 43 cases.The control group were given benazepril hydrochloride,metoprololprolonged-release tablet,hydrochlorothiazide,Spironolactone,Digoxin tablets and trimetazidine treatment.The test group were on the basis of the above plus compound Yixinshu Tablets,3 grains/time,three times daily.Patients in two groups were treated for 12 weeks.Left ventricular ejection fraction(LVEF),interventrieular septum dimension(IVSD),left ventricular end-diastolic diameter(LVEDD) and left ventricular posterior wall thickness(LVPW) were detected though echocardiography and compared before and after treatment.NT-proBNP and Adropin protein were detected and compared before and after treatment.Results After treatment,the total effective rate of control group was 69.8% and the total effective rate of test group was 88.4%,the difference was statistically significant(P<0.05).LVEDD,IVSD and LVPW of the two groups after treatment were significantly lower than those of previous treatment(P<0.05),and LVEDD,IVSD,LVPW in test group were lower than control group after treatment(P<0.05).The LVEF of the two groups was significantly increased after treatment,while the NT-proBNP and Adropin protein significantly decreased,the difference was statistically significant(P<0.05).LVEF of test group was higher than the control group after treatment,while the NT-proBNP and Adropin protein of the test group were significantly lower than the control group after treatment,the differences were statistically significant(P<0.05).Conclusion Yixinshu Tablets combined with trimetazidine has good clinical effect in treatment of CHF,which can delay the progress of disease and improve the symptoms of heart failure.
查看全文     下载PDF阅读器
关闭
分享按钮